Hair Screening and its potential for pharmaceutical R&D
Overtime validation and traceability of new medication
Date: April 18th
Time: 10.00 – 12.00 (ending with included lunch)
Location: Meeting room 1 Chesbrough Building
Registration by e-mail
Founded in 2018, Hair Diagnostics(x) (HDX®) is a Dutch medical technology startup based in Maastricht, the Netherlands. The company develops specialist, high accuracy, non-invasive and substance testing, and monitors solutions for the use of researchers, physicians, pharmaceutical professional and drug-testing authorities.
HDX® is a subsidiary of the Dutch Screening Group (DSG), a Netherlands-based consortium involving Maastricht University, Maastricht University Medical Center (MUMC), M4I, and BL Investment Group BV. More information can be found at https://www.hdx-dsg.com/.